Definition
Good Pharmacovigilance Practice, or GVP, refers to the quality framework that supports the design, management, and oversight of pharmacovigilance systems. It helps organizations maintain consistent processes for case handling, signal review, reporting, and ongoing safety monitoring.
It is important because pharmacovigilance functions depend on both scientific judgment and disciplined operational controls. Without clear structure, safety work can become inconsistent and difficult to defend during review or inspection.
Why It Matters
Good Pharmacovigilance Practice supports reliable safety operations and better decision-making across the product lifecycle. It helps teams work from clear expectations and reduces the chance of gaps in case management, documentation, or oversight.
It connects closely with pharmacovigilance, ICSR, and signal detection.
Key Components
Good Pharmacovigilance Practice includes case intake and processing, adverse event assessment, aggregate review, signal management, and regulatory reporting. It also covers training, documentation, oversight, and the mechanisms that ensure pharmacovigilance processes are consistent and auditable.
Strong GVP systems are built on a clear division of responsibilities, documented procedures, and the ability to demonstrate how safety decisions were made.
Practical Benefits
Applying Good Pharmacovigilance Practice helps organizations reduce operational risk and improve confidence in the safety data they generate. It also makes it easier to respond to regulatory inquiries, inspections, and internal governance reviews.
For teams in Nigeria, it supports the reliable management of case reports, signal review, and compliant safety communication to local regulators and stakeholders.
How It Relates to MedNova
MedNova helps organizations build and strengthen pharmacovigilance systems that are practical, auditable, and aligned with real-world operational needs. Our support spans both process design and day-to-day execution.
We regularly support clients who need a stronger link between compliance expectations and the everyday work of drug safety teams.
Related Terms